Patents by Inventor William S. Ammons

William S. Ammons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5578568
    Abstract: The present invention provides methods of treating adverse physiological effects associated with intestinal ischemia reperfusion by administering to a subject suffering from the effects of intestinal ischemia reperfusion an effective amount of a BPI protein product.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: November 26, 1996
    Assignee: XOMA Corporation
    Inventors: William S. Ammons, K aroly M. M esz aros
  • Patent number: 5447913
    Abstract: Improved therapeutic uses of bactericidal/permeability-increasing protein (BPI) involve use of BPI protein product formulations in the form of physiologically stable dimeric associations of BPI protein product monomers characterized by enhanced in vivo biological activity. Preferred formulations include 50 percent or more by weight dimeric product.
    Type: Grant
    Filed: March 11, 1994
    Date of Patent: September 5, 1995
    Assignee: Xoma Corporation
    Inventors: William S. Ammons, Roger G. Little
  • Patent number: 4388318
    Abstract: The method of treating endotoxin shock with 2,2'-[(4,8-bis(diethylamino)-pyrimido[5,4-d]pyrimidine-2,6-diyl)di-(2-meth oxyethyl)imino]diethanol or a non-toxic, pharmacologically acceptable acid addition salt thereof.
    Type: Grant
    Filed: September 29, 1981
    Date of Patent: June 14, 1983
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Shozo Koyama, John W. Manning, Jr., William S. Ammons, Hector L. Santiesteban